Altre lingue Ascelia Pharma AB

Azioni

ACE

SE0010573113

Biotecnologia

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 12/06/2026			Variaz. 5gg	Var. 1 gen.
2,810 ^SEK	+0,90%		-3,10%	-12,60%

21/05	Ascelia Pharma AB - Analyst/Investor Day
13/05	Ascelia Pharma AB, Q1 2026 Earnings Call, May 13, 2026

Altre lingue

09/06	Orviglance Data Presented Today at the Annual Radiology Congress ESGAR 2026
13/05	Ascelia Pharma (Q1 review): PDUFA-date closing in
12/05	Ascelia Pharma: Less than two months to PDUFA date – Q1 review
12/05	Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones
12/05	Quarterly Report Q1 2026: Orviglance® Approaching Transformative Milestones
12/05	Ascelia Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2026
04/05	Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026
30/04	Change in Number of Shares and Votes in Ascelia Pharma AB
24/04	Ascelia Pharma: Fuelling up ahead of PDUFA date
23/04	Ascelia Pharma Carries Out a Directed Share Issue of SEK 20 Million
09/04	Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026
09/04	Ascelia Pharma AB Auditor Raises 'Going Concern' Doubt
30/03	Notice of Annual General Meeting in Ascelia Pharma AB
27/03	ASCELIA PHARMA ANNOUNCES ACCEPTANCE OF ORVIGLANCE DATA FOR ORAL PRESENTATION AT THE ANNUAL RADIOLOGY CONGRESS ESGAR 2026
10/02	Ascelia Pharma (Q4 review): On the path to approval
05/02	Ascelia Pharma: Few Nordic biotechs get this far – Q4 review
05/02	Ascelia Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
05/02	Ascelia Pharma Q4 EPS loss narrows to SEK 0.13
05/02	Full Year and Q4 Report 2025: FDA Accepts Orviglance NDA for Review
21/01	Ascelia Pharma Deputy CEO, CFO to Step Down
21/01	Ascelia Pharma CFO, Deputy CEO Julie Waras Brogren to leave
21/01	Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company
21/01	Ascelia Pharma AB Announces Departure of Julie Waras Brogren as Deputy CEO
22/12	Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB
28/11	Change in Number of Shares and Votes in Ascelia Pharma AB